These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 18540364

  • 1. [Plasmapheresis in patients with myasthenia gravis].
    Konishi T.
    Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
    [Abstract] [Full Text] [Related]

  • 2. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF, Wang WX, Xue J, Zhao CB, You HZ, Lu JH, Gu Y.
    Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
    [Abstract] [Full Text] [Related]

  • 3. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
    Pittayanon R, Treeprasertsuk S, Phanthumchinda K.
    J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
    [Abstract] [Full Text] [Related]

  • 4. Prethymectomy plasmapheresis in myasthenia gravis.
    Yeh JH, Chen WH, Huang KM, Chiu HC.
    J Clin Apher; 2005 Dec; 20(4):217-21. PubMed ID: 16035101
    [Abstract] [Full Text] [Related]

  • 5. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
    Köhler W, Bucka C, Klingel R.
    J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
    [Abstract] [Full Text] [Related]

  • 6. Treatment of myasthenia gravis with dropped head: a report of 2 cases and review of the literature.
    Tamai M, Hashimoto T, Isobe T, Sato H, Doden T, Nakano T.
    Neuromuscul Disord; 2015 May; 25(5):429-31. PubMed ID: 25747003
    [Abstract] [Full Text] [Related]

  • 7. Experience in the treatment of myasthenia gravis with double filtration plasmapheresis.
    Chuang YC, Lee CT, Chen JB, Chee EC.
    Chang Gung Med J; 2000 Feb; 23(2):80-6. PubMed ID: 10835802
    [Abstract] [Full Text] [Related]

  • 8. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
    Yeh JH, Chiu HC.
    J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
    [Abstract] [Full Text] [Related]

  • 9. Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis.
    Yeh JH, Chiu HC.
    J Neurol; 2000 Jul; 247(7):510-3. PubMed ID: 10993491
    [Abstract] [Full Text] [Related]

  • 10. Plasmapheresis in the treatment of myasthenia gravis.
    Lenzhofer R, Graninger W, Dittrich C, Mamoli B, Zeitlhofer J, Pateisky K.
    Wien Klin Wochenschr; 1983 Apr 15; 95(8):266-71. PubMed ID: 6603717
    [Abstract] [Full Text] [Related]

  • 11. Plasmapheresis does not affect polysomnographic parameters in patients with myasthenia gravis: a case series study.
    Yeh JH, Chen WH, Chiu HC, Lee CT, Hsu CY.
    Artif Organs; 2010 Jun 15; 34(6):E200-3. PubMed ID: 20456321
    [Abstract] [Full Text] [Related]

  • 12. The outcome of thymectomy in nonthymomatous myasthenia gravis.
    Huang MH, King KL, Hsu WH, Huang BS, Hsu HK, Wang LS, Chien KY.
    Surg Gynecol Obstet; 1988 May 15; 166(5):436-40. PubMed ID: 3363464
    [Abstract] [Full Text] [Related]

  • 13. MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis.
    Yeh JH, Chen WH, Chiu HC, Bai CH.
    J Neurol Sci; 2007 Dec 15; 263(1-2):191-3. PubMed ID: 17602704
    [Abstract] [Full Text] [Related]

  • 14. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis.
    Liew WK, Powell CA, Sloan SR, Shamberger RC, Weldon CB, Darras BT, Kang PB.
    JAMA Neurol; 2014 May 15; 71(5):575-80. PubMed ID: 24590389
    [Abstract] [Full Text] [Related]

  • 15. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S, Janzen RW, Mohs C, Pohlmann S, Klingel R, Grützmacher PW.
    Dtsch Med Wochenschr; 2008 Nov 15; 133(46):2377-82. PubMed ID: 18988129
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic apheresis in myasthenia gravis.
    Batocchi AP, Evoli A, Di Schino C, Tonali P.
    Ther Apher; 2000 Aug 15; 4(4):275-9. PubMed ID: 10975473
    [Abstract] [Full Text] [Related]

  • 17. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitler LE.
    N Engl J Med; 1977 Nov 24; 297(21):1134-40. PubMed ID: 917042
    [Abstract] [Full Text] [Related]

  • 18. Myasthenia gravis: treatment with plasma exchange experiences over 10 years.
    Fornádi L, Horváth R, Szobor A.
    Acta Med Hung; 1991 Nov 24; 48(3-4):137-44. PubMed ID: 1822852
    [Abstract] [Full Text] [Related]

  • 19. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
    Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C.
    Ann Neurol; 1997 Jun 24; 41(6):789-96. PubMed ID: 9189040
    [Abstract] [Full Text] [Related]

  • 20. Myasthenia gravis: effect of immunoactive therapies.
    Fornádi L, Horváth R, Bárdosi Z, Szobor A.
    Acta Med Hung; 1994 Jun 24; 50(1-2):83-92. PubMed ID: 7638045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.